Antares Pharma (NASDAQ: ATRS) announced that it has priced a firm commitment underwritten public offering of 20,000,000 shares of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE